LY2090314 (GMP)

Overview

LY2090314 (GMP) is LY2090314 ( HY-16294 ) produced by using GMP guidelines. GMP small molecules works appropriately as an auxiliary reagent for cell therapy manufacture. LY2090314 is a potent inhibitor of glycogen synthase kinase-3 ( GSK-3 ) with IC 50 values of 1.5 nM and 0.9 nM for GSK-3α and GSK-3β , respectively.

Application

Products | Products > GMP Small Molecules | Products > Disease Areas > Cancer | Products > Signaling Pathways > PI3K/Akt/mTOR | Products > Signaling Pathways > Stem Cell/Wnt | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Stem Cells | Products > Research Areas > Cancer > Cancer Drug Resistance | Products > Signaling Pathways > GSK-3

Product Information

• Catalog No.: HY-16294G
• CAS No.: 603288-22-8
• Molecular Formula: C28H25FN6O3
• Molecular Weight: 512.53
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source